Evidence map›Paper›PMID 31866099›Full record

Trial reportThe Journal of allergy and clinical immunology2020

Reduction in mouse allergen exposure is associated with greater lung function growth.

Torie Grant, Wanda Phipatanakul, Matthew Perzanowski, Susan Balcer-Whaley, Roger D Peng, Jean Curtin-Brosnan, Michelle Newman, Amparito Cunningham, Adnan Divjan, Mary E Bollinger and 2 more

Open access · bronzeAbstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in The Journal of allergy and clinical immunology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 34 citations in OpenAlex.

  1. Trial
  2. The Impact of the Indoor Environment on Childhood Asthma.Current allergy and asthma reports · 2025
    Review
  3. Review
  4. Minimizing Indoor Allergen Exposure: What Works?Current allergy and asthma reports · 2024
    Review
  5. Relationships between lung function, allergy, and wheezing in urban children.The Journal of allergy and clinical immunology · 2024
    Article
  6. Impact of socioeconomic factors on allergic diseases.The Journal of allergy and clinical immunology · 2024
    Review
  7. Article
  8. Indoor Environmental Exposures and Their Relationship to Allergic Diseases.The journal of allergy and clinical immunology. In practice · 2023
    Article
  9. Article
  10. Allergic rhinitis co-morbidity on asthma outcomes in city school children.The Journal of asthma : official journal of the Association for the Care of Asthma · 2023
    Article
  11. Review
  12. Update on indoor allergens and their impact on pediatric asthma.Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology · 2022
    Review
  13. The influence of urban exposures and residence on childhood asthma.Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology · 2022
    Review
  14. Review
  15. Observational
  16. Asthma and the social determinants of health.Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology · 2022
    Review
  17. 2020 Updated Asthma Guidelines: Indoor allergen reduction.The Journal of allergy and clinical immunology · 2020
    Article
  18. Indoor Air Pollution and Respiratory Health.Clinics in chest medicine · 2020
    Review
  19. Article
  20. Childhood Origins of Adult Lung Disease as Opportunities for Prevention.The journal of allergy and clinical immunology. In practice · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 1 country.

Torie GrantDivision of Pediatric Allergy/Immunology, Johns Hopkins University School of Medicine, Baltimore, Md.
Wanda PhipatanakulDivision of Pediatric Allergy/Immunology, Boston Children's Hospital, Harvard University Medical School, Boston, Mass.
Matthew PerzanowskiDepartment of Environmental Health Sciences, Mailman School of Public Health, Columbia University, New York, NY.
Susan Balcer-WhaleyDivision of Pediatric Allergy/Immunology, Johns Hopkins University School of Medicine, Baltimore, Md.
Roger D PengDepartment of Biostatistics, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Md.
Jean Curtin-BrosnanDivision of Pediatric Allergy/Immunology, Johns Hopkins University School of Medicine, Baltimore, Md.
Michelle NewmanDivision of Pediatric Allergy/Immunology, Johns Hopkins University School of Medicine, Baltimore, Md.
Amparito CunninghamDivision of Pediatric Allergy/Immunology, Boston Children's Hospital, Harvard University Medical School, Boston, Mass.
Adnan DivjanDepartment of Environmental Health Sciences, Mailman School of Public Health, Columbia University, New York, NY.
Mary E BollingerDepartment of Pediatrics, University of Maryland School of Medicine, Baltimore, Md.
Robert A WiseDivisions of Pulmonary and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, Md.
Elizabeth C MatsuiDivision of Pediatric Allergy/Immunology, Johns Hopkins University School of Medicine, Baltimore, Md; Departments of Population Health and Pediatrics, Dell Medical School at University of Texas at Austin, Austin, Tex. Electronic address: elizabeth.matsui@austin.utexas.edu.
Johns Hopkins University · USBoston Children's Hospital · USColumbia University · USJohns Hopkins Medicine · USUniversity of Maryland, Baltimore · US

Funding

True Metal fac coreP30ES009089 · NIEHS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI MATTHEW S PERZANOWSKI · 1998 to 2026
$44.7M
Oxidative Stress & Inflammation in a Human PM Nasal ChallengeP50ES015903 · NIEHS · JOHNS HOPKINS UNIVERSITY · PI BREYSSE, PATRICK N · 2007 to 2011
$12.1M
Mouse Allergen and Asthma Intervention TrialU01AI083238 · NIAID · JOHNS HOPKINS UNIVERSITY · PI MATSUI, ELIZABETH C. · 2010 to 2014
$7.9M
The effect of a housing mobility program on environmental exposures and asthma morbidity among low-income minority childrenR01ES026170 · NIEHS · JOHNS HOPKINS UNIVERSITY · PI KEET, CORINNE, MATSUI, ELIZABETH C. · 2016 to 2025
$6.8M
Scientific & Technical CoreP2CHD042849 · NICHD · UNIVERSITY OF TEXAS AT AUSTIN · PI Elizabeth T. Gershoff · 2017 to 2026
$5.2M
The role of obesity in biological responses to particulate matter in miceP50ES018176 · NIEHS · JOHNS HOPKINS UNIVERSITY · PI HANSEL, NADIA N · 2015 to 2019
$4.8M
Project 3: Dissecting the Diet Asthma Relationship in Mice Models of AsthmaP01ES018176 · NIEHS · JOHNS HOPKINS UNIVERSITY · PI BISWAL, SHYAM · 2009 to 2013
$4.2M
Environmental Control as Add-on Therapy in Urban Children with AsthmaR01ES023447 · NIEHS · JOHNS HOPKINS UNIVERSITY · PI MATSUI, ELIZABETH C. · 2014 to 2018
$3.4M
Mouse Allergen and Inner-City AsthmaR01AI070630 · NIAID · JOHNS HOPKINS UNIVERSITY · PI MATSUI, ELIZABETH C. · 2006 to 2010
$1.9M
Midcareer Investigator Award: Urban School Allergen Exposures and Childhood AsthmK24AI106822 · NIAID · BOSTON CHILDREN'S HOSPITAL · PI PHIPATANAKUL, WANDA · 2013 to 2022
$1.9M
Mentoring in Patient-Oriented Research on Asthma and the Indoor EnvironmentK24AI114769 · NIAID · UNIVERSITY OF TEXAS AT AUSTIN · PI MATSUI, ELIZABETH C. · 2015 to 2023
$1.6M
Mouse Allergen Exposure &Mouse Allergic SensitizationK23AI060955 · NIAID · JOHNS HOPKINS UNIVERSITY · PI MATSUI, ELIZABETH C. · 2005 to 2007
$404k
NIAID NIH HHS K23 AI060955NIAID NIH HHS K24 AI106822NIAID NIH HHS K24 AI114769NIAID NIH HHS R01 AI070630NIAID NIH HHS R34 AI074928NIAID NIH HHS U01 AI083238NICHD NIH HHS P2C HD042849NIEHS NIH HHS P01 ES018176NIEHS NIH HHS P30 ES009089NIEHS NIH HHS P50 ES015903NIEHS NIH HHS P50 ES018176NIEHS NIH HHS R01 ES023447NIEHS NIH HHS R01 ES026170
6 · The paper itself

Abstract

backgroundCurrent childhood asthma therapies have little effect on lung function trajectory.

objectiveWe sought to determine whether mouse allergen exposure reduction is associated with lung function growth in mouse-sensitized/exposed asthmatic children.

methodsThree hundred fifty mouse-sensitized/exposed asthmatic children (5-17 years old) were enrolled in a 1-year randomized trial of integrated pest management plus education versus education alone. Prebronchodilator/postbronchodilator spirometry was performed at baseline and 6 and 12 months, and bedroom floor mouse allergen levels were measured every 3 months. Mouse allergen reduction was defined as a 75% or greater decrease in mouse allergen levels from baseline. Treatment groups were combined for analyses because there were no differences in outcomes between groups. Changes in lung function over time were modeled, adjusting for age, sex, race, atopy, group, and bronchodilator reversibility and including an interaction term (allergen reduction*time).

resultsThe study population was predominantly black (79.4%) and low income (66.3% [<$30,000]). At baseline, the median mouse allergen level was 5.7 μg/g (interquartile range, 1.5-22.8 μg/g), and the mean (SD) prebronchodilator FEV

conclusionMouse allergen reduction is associated with greater increases in prebronchodilator FEV

Indexed as

AllergensAdolescentAnimalsAsthmaChildChild, PreschoolEnvironmental ExposureFemaleHumansHypersensitivity, ImmediateMaleMicePatient Education as TopicPest ControlRespiratory Function TestsAllergensAllergen exposureallergen exposure reductionallergen-sensitized and exposed asthmatic childrenallergic asthmalung function growthlung function trajectorymouse allergen exposure

Identifiers

PMID31866099
PMCPMC7046077
OpenAlexW2994622122

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.